Skip to main content
ISSCR 2025 Annual Meeting Main banner

Yasunori Aizawa, PhD

Logomix, Inc., Japan

With an original background in pharmaceutical science and bio-organic chemistry, Dr. Aizawa brings over 20 years of expertise in functional human genomics. In exploring the biological significance of non-coding regions including retrotransposons, introns, and long noncoding RNAs, which occupy the 98-99% of the human genome, he has developed innovative methodologies to precisely and efficiently engineer sub-megabase-scale genomic regions and assess the functional meanings of these regions in living human cells. After co-founding Logomix Inc. in 2019, Dr. Aizawa established and continuously refined a large-scale human genome engineering platform capable of high-throughput manipulation of intracellular genetic networks in iPSCs. This platform is already driving the development of next-generation therapeutic cell modalities, and Dr. Aizawa’s team is working to further accelerate that progress through automation and a variety of compact AI systems, leading to a new algorithm for the design and control of intracellular systems of iPSCs.

Presentation(s):